Back to Results
First PageMeta Content
Emotion / Antidepressant / Organofluorides / Major depressive disorder / Food and Drug Administration / Suicide / Desvenlafaxine / Fluoxetine / Chemistry / Psychiatry / Selective serotonin reuptake inhibitors


MEMORANDUM DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH SERVICE FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH
Add to Reading List

Open Document

File Size: 16,46 KB

Share Result on Facebook

Company

Safety Group / /

Country

Columbia / /

Facility

Duke University / Columbia University / /

IndustryTerm

antidepressant products / /

MedicalCondition

insomnia / panic attacks / major depressive disorder / bipolar depression / psychomotor restlessness / psychiatric illness / mania / pediatric major depressive disorder / depression / bipolar disorder / akathisia / /

Organization

Duke University / Columbia University / FOOD AND DRUG ADMINISTRATION CENTER FOR DRUG EVALUATION AND RESEARCH DATE / FDA / Psychiatric Drug Products Division of Neuropharmacological Drug Products HFD-120 SUBJECT / office of Counter Terrorism and Pediatrics / Pediatric Drugs Advisory Committee / Division of Neuropharmacological Drug Products / DEPARTMENT OF HEALTH AND HUMAN SERVICES / Psychopharmacological Drugs Advisory Committee / Advisory Committee / office of Drug Safety / /

Person

Psychiatric Drug / Kelly Posner / Tarek Hammad / Solomon Iyasu / John March / Andrew Mosholder / Thomas P. Laughren / Greg Dubitsky / Diane Wysowski / /

Position

Team Leader / M.D. Team Leader / /

Technology

drug development / /

URL

http /

SocialTag